MedPath

A pilot study of internet cognitive therapy for social anxiety disorder in Japa

Phase 2
Conditions
Social anxiety disorder
Registration Number
JPRN-UMIN000044810
Lead Sponsor
niversity of Miyazaki
Brief Summary

iCT-SAD led to significant improvements in social anxiety symptoms during the treatment phase, and these improvements were maintained during the follow-up phase. Similar results were observed for the secondary outcome measures. At the end of the treatment phase, 80% of participants demonstrated reliable improvement, and 60% of participants demonstrated remission from social anxiety. No serious adverse events occurred.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

Currently receiving any other psychological intervention Previously received cognitive/behavioural therapy for social anxiety disorder Intellectual disability or intellectual developmental disorder Current alcohol or substance dependence Presence or suspected presence of psychosis, bipolar disorder or serious personality disorder Suicidal intent or recurrent self-harming behavior Neurologic or neuropsychiatric disorder that adversely affects the cognitive performance

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath